GSK-3beta inhibitor 7 is a GSK-3beta inhibitor (IC50: 5.25 µM) that acts by inserting into the ATP-binding pocket of GSK-3beta and forming hydrogen bonds. It exhibits a high rate of glucose uptake by hepatocytes (83.5%) and can be used to study various diseases such as cancer, diabetes, inflammation, Alzheimers disease, and bipolar disorder.
Molecular Weight:
547.47
Formula:
C27H23BrN4O2S
Target:
Others|||GSK-3
* VAT and and shipping costs not included. Errors and price changes excepted
